Brief: Mayne Pharma Group Fulfils Imvexxy Post-Marketing Study Requirements
09/10/2026 02:16
BRIEF-Mayne Pharma Group Fulfils Imvexxy Post-Marketing Study Requirements Oct 9 (Reuters) - Mayne Pharma Group Ltd MYX.AX:
FULFILMENT OF IMVEXXY POST-MARKETING STUDY REQUIREMENTS
Further company coverage: MYX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)